Anxiety Relief

April 4, 2022


A quick read offering a brief snapshot of the past 5,000 years of Pharmacological Cannabis use and some of the most significant findings since Western Medicine has adopted its use in the past 180 years, this paper establishes (from multiple sources) Cannabis' prowess and widespread use across many cultures and epochs as a critical pharmacological treatment for ailments such as acute and chronic pain, convulsive disorders, rheumatism, opiate addiction, and more.
October 22, 2021


The high MC monthly dose group consumed higher levels of most phyto-cannabinoids and terpenes, but that was not the case for all of the cannabis components. The high dose consumers and the ones with lower ASRS score reported a higher occurrence of stopping all ADHD medications. Moreover, there was an association between lower ASRS score subgroup and lower anxiety scores. In addition, we found an association between lower ASRS score and consumption of high doses of cannabinol (CBN), but not with Δ-9-tetrahydrocannabinol (THC). Conclusion: These findings reveal that the higher-dose consumption of MC components (phyto-cannabinoids and terpenes) is associated with ADHD medication reduction. In addition, high dosage of CBN was associated with a lower ASRS score. However, more studies are needed in order to fully understand if cannabis and its constituents can be used for management of ADHD.
    Your Cart
    Your cart is emptyReturn to Shop